Searching across hundreds of databases
Prenatal testosterone (T) excess in sheep leads to peripheral insulin resistance (IR), reduced adipocyte size, and tissue-specific changes, with liver and muscle but not adipose tissue being insulin resistant. To determine the basis for the tissue-specific differences in insulin sensitivity, we assessed changes in negative (inflammation, oxidative stress, and lipotoxicity) and positive mediators (adiponectin and antioxidants) of insulin sensitivity in the liver, muscle, and adipose tissues of control and prenatal T-treated sheep. Because T excess leads to maternal hyperinsulinemia, fetal hyperandrogenism, and functional hyperandrogenism and IR in their female offspring, prenatal and postnatal interventions with antiandrogen, flutamide, and the insulin sensitizer rosiglitazone were used to parse out the contribution of androgenic and metabolic pathways in programming and maintaining these defects. Results showed that (1) peripheral IR in prenatal T-treated female sheep is related to increases in triglycerides and 3-nitrotyrosine, which appear to override the increase in high-molecular-weight adiponectin; (2) liver IR is a function of the increase in oxidative stress (3-nitrotyrosine) and lipotoxicity; (3) muscle IR is related to lipotoxicity; and (4) the insulin-sensitive status of visceral adipose tissue appears to be a function of the increase in antioxidants that likely overrides the increase in proinflammatory cytokines, macrophages, and oxidative stress. Prenatal and postnatal intervention with either antiandrogen or insulin sensitizer had partial effects in preventing or ameliorating the prenatal T-induced changes in mediators of insulin sensitivity, suggesting that both pathways are critical for the programming and maintenance of the prenatal T-induced changes and point to potential involvement of estrogenic pathways.
Pubmed ID: 28911168 RIS Download
Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.
This monoclonal targets GAPDH
View all literature mentionsThis monoclonal targets AMPK (D63G4)
View all literature mentionsThis monoclonal targets Phospho-AMPK (Thr172) (D79.5E) Rabbit mAb
View all literature mentionsThis polyclonal targets Adiponectin
View all literature mentionsThis monoclonal targets GAPDH
View all literature mentionsThis monoclonal targets AMPK (D63G4)
View all literature mentionsThis monoclonal targets Phospho-AMPK (Thr172) (D79.5E) Rabbit mAb
View all literature mentionsThis monoclonal targets Phospho-AMPK (Thr172) (D79.5E) Rabbit mAb
View all literature mentionsThis polyclonal targets Adiponectin
View all literature mentionsThis monoclonal targets AMPK (D63G4)
View all literature mentionsThis monoclonal targets GAPDH
View all literature mentionsThis polyclonal targets Adiponectin
View all literature mentionsThe SciCrunch Infrastructure was developed as a cooperative data platform to be used by diverse communities in making data more FAIR.
scicrunch.org
